Mitogenic and progenitor gene programmes in single pilocytic astrocytoma cells ZJ Reitman, BR Paolella, G Bergthold, K Pelton, S Becker, R Jones, ... Nature communications 10 (1), 3731, 2019 | 65 | 2019 |
Pathways impacted by genomic alterations in pulmonary carcinoid tumors MK Asiedu, CF Thomas Jr, J Dong, SC Schulte, P Khadka, Z Sun, ... Clinical Cancer Research 24 (7), 1691-1704, 2018 | 64 | 2018 |
Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastoma P Bandopadhayay, F Piccioni, R O’Rourke, P Ho, EM Gonzalez, ... Nature communications 10 (1), 2400, 2019 | 51 | 2019 |
The landscape of chromosomal aberrations in breast cancer mouse models reveals driver-specific routes to tumorigenesis U Ben-David, G Ha, P Khadka, X Jin, B Wong, L Franke, TR Golub Nature communications 7 (1), 12160, 2016 | 50 | 2016 |
Single cell spatial analysis reveals the topology of immunomodulatory purinergic signaling in glioblastoma S Coy, S Wang, SA Stopka, JR Lin, C Yapp, CC Ritch, L Salhi, GJ Baker, ... Nature communications 13 (1), 4814, 2022 | 41 | 2022 |
PPM1D mutations are oncogenic drivers of de novo diffuse midline glioma formation P Khadka, ZJ Reitman, S Lu, G Buchan, G Gionet, F Dubois, DM Carvalho, ... Nature communications 13 (1), 604, 2022 | 37 | 2022 |
Structural variants shape driver combinations and outcomes in pediatric high-grade glioma FPB Dubois, O Shapira, NF Greenwald, T Zack, J Wala, JW Tsai, A Crane, ... Nature cancer 3 (8), 994-1011, 2022 | 22 | 2022 |
HGG-60. Structural variants shape driver combinations and outcomes in pediatric high-grade glioma F Dubois, O Shapira, N Greenwald, T Zack, J Wala, J Tsai, A Crane, ... Neuro-Oncology 24 (Supplement_1), i75-i76, 2022 | | 2022 |
DIPG-54. p53 pathway reactivation as a therapeutic strategy in diffuse intrinsic pontine glioma L Lupien, V Rendo, E Morin, N Khuu, J DiGiacomo, P Khadka, M Chacon, ... Neuro-Oncology 24 (Suppl 1), i31, 2022 | | 2022 |
LGG-45. Genetic dependencies inMYB/MYBL1-driven pediatric low-grade glioma models AL Condurat, J Jones, E Gonzalez, J Doshi, K Zhou, JW Tsai, P Khadka, ... Neuro-oncology 24 (Suppl 1), i98, 2022 | | 2022 |
RARE-22 Characterizing the landscape of structural variants in adamantinomatous craniopharyngioma D Jomaa, P Khadka, D Novikov, AL Condurat, JW Tsai, F Dubois, ... Neuro-Oncology 24 (Supplement_1), i14-i14, 2022 | | 2022 |
OPTIMIZING MDM2 INHIBITION FOR THE TREATMENT OF HIGH-GRADE GLIOMA V Rendo, L Lupien, N Khuu, K Pelton, L Elcavage, S Lu, P Khadka, ... NEURO-ONCOLOGY 23, 77-77, 2021 | | 2021 |
OMRT-6. Optimizing MDM2 inhibition for the treatment of high-grade glioma V Rendo, L Lupien, N Khuu, K Pelton, S Lu, P Khadka, J Langhnoja, ... Neuro-Oncology Advances 3 (Supplement_2), ii8-ii8, 2021 | | 2021 |
Phenogenomic characterization of immunomodulatory purinergic signaling in glioblastoma S Coy, JR Lin, S Wang, S Stopka, R Rashid, J Hwang, P Khadka, ... Cancer Research 81 (13_Supplement), 1816-1816, 2021 | | 2021 |
RARE-07. THE LANDSCAPE OF GENOMIC ALTERATIONS IN ADAMANTINOMATOUS CRANIOPHARYNGIOMAS P Khadka, E Prince, S Lu, S Santagata, K Ligon, P Manley, R Beroukhim, ... Neuro-Oncology 22 (Suppl 3), iii443, 2020 | | 2020 |
DIPG-53. CHARACTERIZING THE ROLE OF PPM1D MUTATIONS IN THE PATHOGENESIS OF DIFFUSE INTRINSIC PONTINE GLIOMAS (DIPGS) P Khadka, Z Reitman, S Lu, G Buchan, R Hartley, H Bear, Y Georgis, ... Neuro-Oncology 22 (Suppl 3), iii297, 2020 | | 2020 |
LGG-35. FUNCTIONAL GENOMIC APPROACHES TO IDENTIFY THERAPEUTIC TARGETS IN MYB AND MYBL1 EXPRESSING PEDIATRIC LOW-GRADE … AL Condurat, A Wefers, E Gonzalez, J Doshi, P Khadka, S Jessa, J Tsai, ... Neuro-Oncology 22 (Supplement_3), iii373-iii373, 2020 | | 2020 |
DIPG-22. DISSECTING THE ONCOGENIC ROLE OF FOXR2 IN DIFFUSE INTRINSIC PONTINE GLIOMA JW Tsai, SK Patel, H Bear, F Dubois, P Khadka, S Lu, E Gonzalez, ... Neuro-Oncology 22 (Supplement_3), iii291-iii291, 2020 | | 2020 |
TAMI-45. PHENOGENOMIC CHARACTERIZATION OF IMMUNOMODULATORY PURINERGIC SIGNALING IN GLIOBLASTOMA S Coy, R Rashid, S Stopka, JR Lin, P Euskirchen, J Hwang, P Khadka, ... Neuro-Oncology 22 (Supplement_2), ii222-ii223, 2020 | | 2020 |
DIPG-12. CHARACTERIZING THE ROLE OF PPM1D MUTATIONS IN THE PATHOGENESIS OF DIFFUSE INTRINSIC PONTINE GLIOMAS (DIPGs) P Khadka, ZJ Reitman, G Buchan, R Hartley, H Bear, Y Georgis, ... Neuro-Oncology 21 (Supplement_2), Pages ii70–ii71, 2019 | | 2019 |